Sabitlenmiş Tweet
Jay Peredo
14.9K posts
Jay Peredo
@jayperedox
peptide connoisseur @peptracker | prev many places, many things (2x exits)
Salt Lake City, UT Katılım Eylül 2010
424 Takip Edilen12.8K Takipçiler
@brettcalhounn submitted @PepTracker’s pitch a couple weeks ago! would love to chat.
English
Redbud VC is actively seeking our next investments.
What we're looking for:
→ Founders with proven resilience
→ Teams that turn obstacles into opportunities
→ Companies built to last
We believe the greatest results come from those who refuse to give up. If that's you, pitch us.⬇️
English
retatrutide WILL become the #1 selling drug in the world.
Bryan Johnson@bryan_johnson
These numbers are shocking. It's like we got a new frontier AI model but for the body. Lilly's phase 3 results for retatrutide: > highest dose lost 28.3% of body weight in 80 wks > 70 lbs ave > 45% lost 30% or more of their body weight > 65% on the top dose no longer clinically obese Retatrutide is more dynamic than semaglutide and tirzepatide because it targets three receptors (GIP, GLP-1, and glucagon), versus one and two, respectively. Side effects, on the highest dose (12mg), were higher for retatrutide than tirzepatide (nausea and GI), with an 11.3% drop out rate. The lowest 4mg dose still delivered 19% loss with fewer dropouts than placebo.
English
@alexxgrowth damn would be interested in learning more! i’ve tried another platform and it just didn’t work for my app
English
all the most successful startups are all doing this rn
they have multiple accounts where they all post different formats, different content, and post them consistently
push out 20 to 30 videos a day, if you post 300 to 1,000 videos a month
there is no way that you are not going to succeed…
but doing that all by yourself is basically trying to push a 50-pound boulder up a mountain
the short cut loop to that is Content Rewards
on Content Rewards, you can launch a campaign, put a budget
suddenly overnight, you have 30+ accounts with your app's branding that are consistently posting for your brand because they want to earn the campaign money
you can specify a viral format, and put them in a drive and get them to your creators
creators will multiply the viral format and post 20, 30, even 50 times a day
and all of this is before you even spend a dollar
you only pay clippers/creators when they generate views for you
$0.12 cents to $1 cpm on verified views only
that's exactly how we're getting brands super bowl level views in such short time and spend
Gaurav@gauravsbuilding
“Why is my app not going viral yet??” You need to be posting consistently, and at scale, before you give up. It’s simple maths. Posting daily across multiple accounts across multiple platforms increases your apps surface area. Look at Cluely’s scale during their peak:
English
Are you taking peptides? If so, what’s your stack? I’ll go first:
- Retatrutide
- Kisspeptin
- Tesamorelin
- Ipamorelin
- MOTS-c
- DSIP
- BPC-157
English
@cormachayden_ insane. happening for me too w/ @PepTracker. so much ai slop peptide apps now…
English
not one to focus on copycats, would rather build heads down, but things are getting out of control
apps are blatantly stealing our app screens, content and creators and lying to users
case 1) macropal
- ripped our screenshots exactly
- app doesn't even match screens
- directly poaching our creators
English
@nikillinit that’s why we’re building the adherence layer for peptides + glps @PepTracker. would love to chat. already working with functional health clinics on this exact problem.
English
I get so many pitch decks now for peptide companies now and basically all of them
1) exclusively focus on their customer acquisition costs, their UGC/video content including AI generated marketing pipelines, and affiliate marketing strategy
2) talk about how fast their turnaround time is to patients and how broad their catalog of peptides are
3) do not talk at all about monitoring patients post prescription
4) they all say they work with the top suppliers to provide legitimacy but don't really have a clear methodology for how they're doing this (esp with so many steps between securing the in ingredient, to shipping, to compounding)
I understand why peptides are popular - but I don't think having more companies who effectively are marketing/dropshipping companies while offloading liability and adverse events to the doctors is the right direction for healthcare
English
@m_goes_distance sending you a dm sir 🫡
building the adherence layer for peptides @peptracker
growing organically and starting to see real pull from clinics around adherence + outcomes
English
Jay Peredo retweetledi
RFK has been saying this was coming for weeks. Now it’s official.
The FDA is removing 12 peptides from the restricted list. BPC-157, MOTS-c, Semax, Epitalon, Thymosin beta-4 among them. Independent scientific review begins in July.
People have been sourcing these through grey markets for years because legitimate access was cut off. That’s what created real risk for real people.
This should never have happened in the first place.
Secretary Kennedy@SecKennedy
Today, we took long-overdue action to restore science, accountability, and the rule of law. In September 2023, the Biden FDA pushed a number of peptides into Category 2 — “Bulk Drug Substances that Raise Significant Safety Risks” — driving a dangerous black market that puts Americans at risk. Now, after nominators withdrew 12 peptides, the FDA will remove them from Category 2 and will bring them to PCAC at its next two meetings, beginning in July—where independent experts will rigorously evaluate each substance on its scientific merits using full clinical, pharmacological, and safety evidence. • BPC-157 • Thymosin beta-4 fragment (LKKTETQ) • Epitalon • GHK-Cu (injectable) • MOTS-c • DSIP (Emideltide) • Dihexa Acetate • Ibutamoren Mesylate • Melanotan II • KPV • Semax (heptapeptide) • Cathelicidin LL-37 This action begins to restore regulated access and will immediately begin shifting demand away from the black market. We will follow the science, enforce the law, and deliver the clarity patients, providers, and pharmacies deserve.
English
After taking dozens of apps to #1 in the App Store, our team went back and analyzed over 100,000 social media posts to trace back what worked
We found 34 hooks that brought in 100's of millions of views and more than 300 others proven to go viral..
and turned all of that into templates you can steal for free
If you run a consumer app and want:
- more installs
- higher App Store rankings
- content that lands with Gen Z
Comment “HOOKS” and I’ll DM you the file.
English
@AbudBakri happens to all of our accounts…the unfortunate cycle.
make a new account, get traction, banned, repeat 😬
English
Can’t make a TikTok video explain peptides but peptide salesman are fine? 😂
Oh well
English
Jay Peredo retweetledi
GLP-1s are doing a lot more than suppressing appetite and the data reflects that.
This is why tracking your protocol matters.
On The Pen™@ManOnThePen
GLP-1’s don’t simply cause you to eat less. They reduce inflammation, reduce cancer, improve arthritis pain, reduce alcohol consumption, protect the heart independent of weight loss, stimulate beta cells in the pancreas, keep you from developing type 2, and generally reduce all cause mortality. 😮💨 So no, you can’t just “eat less” and get the same benefits.
English
Jay Peredo retweetledi
Eli Lilly's orforglipron just got approved as the first GLP-1 pill for weight loss.
A lot of people who passed on injections are about to reconsider.
The barrier to entry just got a lot lower.
Hims House@himshouse
🚨 BREAKING: FDA APPROVES ELI LILLY GLP-1 PILL $LLY $NVO $HIMS
English
Jay Peredo retweetledi
The FDA is expected to lift its ban on injectable peptides from compounding pharmacies.
The regulatory tide is finally shifting.
English
Imagine actually buying your bac water from Amazon in the first place 😅
English
BREAKING: superpower is moving our peptides out of our fridge into a peptide fridge under lock and key
English